List of bibliographic references indexed by Chloroquine (usage thérapeutique)
Number of relevant bibliographic references: 212.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000002 (2021) |
Fabricio Souza Neves [Brésil] | Correlation of the rise and fall in COVID-19 cases with the social isolation index and early outpatient treatment with hydroxychloroquine and chloroquine in the state of Santa Catarina, southern Brazil: A retrospective analysis. |
| 000027 (2021) |
S. Ortonobes Roig [Espagne] ; N. Soler-Blanco ; I. Torrente Jiménez ; E. Van Den Eynde Otero ; M. Moreno-Ari O ; M. G Mez-Valent | [Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients]. |
| 000035 (2021) |
L. Anedda [Italie] ; L. Bianchini ; L. Cuzzolin ; G. Finco ; V. Fanos ; M A Marcialis | What if COVID-19 affects the child: which weapons and how to use them. |
| 000046 (2021) |
Paulo Roberto Bignardi [Brésil] ; Carolina Santos Vengrus [Brésil] ; Bruno Matos Aquino [Brésil] ; Alcindo Cerci Neto [Brésil] | Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials. |
| 000061 (2021) |
Neils Ben Quashie [Ghana] ; Nancy Odurowah Duah-Quashie [Ghana] | Treatment of COVID-19 with Chloroquine: Implication for Malaria Chemotherapy Using ACTs in Disease Endemic Countries. |
| 000080 (2021) |
Rong Qiu ; Jingwei Li ; Yuxuan Xiao ; Ziyi Gao ; Yihang Weng ; Qiran Zhang ; Chengdi Wang ; Hanlin Gong [République populaire de Chine] ; Weimin Li | The therapeutic effect and safety of the drugs for COVID-19: A systematic review and meta-analysis. |
| 000118 (2021) |
Carlo Salvarani [Italie] ; Pamela Mancuso [Italie] ; Federica Gradellini [Italie] ; Nilla Viani [Italie] ; Paolo Pandolfi [Italie] ; Massimo Reta [Italie] ; Giuliano Carrozzi [Italie] ; Gilda Sandri [Italie] ; Gianluigi Bajocchi [Italie] ; Elena Galli [Italie] ; Francesco Muratore [Italie] ; Luigi Boiardi [Italie] ; Nicol Pipitone [Italie] ; Giulia Cassone [Italie] ; Stefania Croci [Italie] ; Anna Maria Marata [Italie] ; Massimo Costantini [Italie] ; Paolo Giorgi Rossi [Italie] | Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy. |
| 000149 (2021) |
Amir Sarayani [États-Unis] ; Brian Cicali [États-Unis] ; Carl H. Henriksen [États-Unis] ; Joshua D. Brown [États-Unis] | Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine. |
| 000161 (2021) |
Eric Prommer [États-Unis] | Safety and Utility of Chloroquine/ Hydroxychloroquine in Palliative Care Patients. |
| 000181 (2021) |
Pravindra Kumar [Inde] ; Ashok Kumar Sah [Inde] ; Greesham Tripathi [Inde] ; Anjali Kashyap [Inde] ; Avantika Tripathi [Inde] ; Rashmi Rao [Inde] ; Prabhu C. Mishra [Inde] ; Koustav Mallick [Inde] ; Amjad Husain [Inde] ; Manoj Kumar Kashyap [Inde] | Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19. |
| 000196 (2021) |
A J J. Lammers [Pays-Bas] ; R M Brohet [Pays-Bas] ; R E P. Theunissen [Pays-Bas] ; C. Koster [Pays-Bas] ; R. Rood [Pays-Bas] ; D W M. Verhagen [Pays-Bas] ; K. Brinkman [Pays-Bas] ; R J Hassing [Pays-Bas] ; A. Dofferhoff [Pays-Bas] ; R. El Moussaoui [Pays-Bas] ; G. Hermanides [Pays-Bas] ; J. Ellerbroek [Pays-Bas] ; N. Bokhizzou [Pays-Bas] ; H. Visser [Pays-Bas] ; M. Van Den Berge [Pays-Bas] ; H. Bax [Pays-Bas] ; D F Postma [Pays-Bas] ; P H P. Groeneveld [Pays-Bas] | Response to correspondence concerning: "Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients". |
| 000200 (2021) |
Marijke Linschoten [Pays-Bas] ; Linda Nab [Pays-Bas] ; Iwan C C. Van Der Horst [Pays-Bas] ; Robert Tieleman [Pays-Bas] ; Folkert W. Asselbergs [Royaume-Uni] | Response to "Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients". |
| 000249 (2021) |
Bianza Moise Bakadia ; Feng He [République populaire de Chine] ; Tiatou Souho [Togo] ; Lallepak Lamboni [Togo] ; Muhammad Wajid Ullah [République populaire de Chine] ; Biaou Ode Boni [République populaire de Chine] ; Abeer Ahmed Qaed Ahmed [République populaire de Chine] ; Biampata Mutu Mukole ; Guang Yang [République populaire de Chine] | Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine. |
| 000289 (2021) |
Edgar Jg Peters [Pays-Bas] ; Didier Collard [Pays-Bas] ; Sander Van Assen [Pays-Bas] ; Martijn Beudel [Pays-Bas] ; Marije K. Bomers [Pays-Bas] ; Jacqueline Buijs [Pays-Bas] ; Lianne R. De Haan [Pays-Bas] ; Wouter De Ruijter [Pays-Bas] ; Renée A. Douma [Pays-Bas] ; Paul Wg Elbers [Pays-Bas] ; Abraham Goorhuis [Pays-Bas] ; Niels C. Gritters Van Den Oever [Pays-Bas] ; Lieve Ghh Knarren [Pays-Bas] ; Hazra S. Moeniralam [Pays-Bas] ; Remy Lm Mostard [Pays-Bas] ; Marian Jr Quanjel [Pays-Bas] ; Auke C. Reidinga [Pays-Bas] ; Roos Renckens [Pays-Bas] ; Joop Pw Van Den Bergh [Pays-Bas] ; Imro N. Vlasveld [Pays-Bas] ; Jonne J. Sikkens [Pays-Bas] | Outcomes of persons with coronavirus disease 2019 in hospitals with and without standard treatment with (hydroxy)chloroquine. |
| 000294 (2021) |
Sanjay Kumar Mishra [Inde] ; Timir Tripathi [Inde] | One year update on the COVID-19 pandemic: Where are we now? |
| 000295 (2021) |
Zheng Zequn [République populaire de Chine] ; Wu Yujia [République populaire de Chine] ; Qian Dingding [République populaire de Chine] ; Lian Jiangfang [République populaire de Chine] | Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel. |
| 000342 (2021) |
T S Brandon Ng ; Kori Leblanc ; Darwin F. Yeung ; Teresa S M. Tsang [Canada] | Medication use during COVID-19: Review of recent evidence. |
| 000362 (2021) |
| Is chloroquine or hydroxychloroquine useful in treating people with COVID-19, or in preventing infection in people who have been exposed to the virus? |
| 000373 (2021) |
Irina Panovska-Stavridis ; Nevenka Ridova ; Tatjana Stojanoska ; Ilir Demiri ; Milena Stevanovic ; Simona Stojanovska ; Tara Ristevska ; Aleksandar Dimkovski ; Venko Filipce ; Aleksandar Dimovski ; Aleksandra Grozdanova | Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021). |
| 000400 (2021) |
Yao Chen ; Mei-Xiu Li ; Guo-Dong Lu ; Han-Ming Shen [République populaire de Chine, Singapour] ; Jing Zhou [Singapour] | Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery. |
| 000427 (2021) |
Marco Infante [Italie, États-Unis] ; Camillo Ricordi [États-Unis] ; Rodolfo Alejandro [États-Unis] ; Massimiliano Caprio [Italie] ; Andrea Fabbri [Italie] | Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Chloroquine (usage thérapeutique)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i \
-Sk "Chloroquine (usage thérapeutique)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdFr.i
|clé= Chloroquine (usage thérapeutique)
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021 |  |
